At 62 years old, this male patient found himself facing the formidable diagnosis of Stage 4 lung cancer with metastasis to the liver, presenting a dire prognosis. Following unsuccessful chemotherapy, masses persisted in the lungs and widespread spread was evident in the liver, as revealed by a CT scan on July 20, 2013. His general condition was alarmingly weak, painting a bleak picture of his health.
62岁的男性患者面临了第四期肺癌并肝转移的严峻诊断，预后十分不容乐观。经历了无效的化疗后，2013年7月20日的CT扫描显示肺部肿块仍然存在，而肝脏广泛转移，患者的整体状况非常虚弱，他的健康前景堪忧。However, with the initiation of ECCT as Treatment for Stage 4 Lung Cancer with Liver Metastasis on July 29, 2013, after just three months of ECCT treatment, a significant turnaround was witnessed. A follow-up CT scan on October 21, 2013, yielded promising results: no detectable masses were found in the lungs, and the majority of liver masses had either disappeared or drastically reduced in size. Although some nodules remained in the liver, indicating dead mass deposits, their reduced size indicated progress.
然而，2013年7月29日开始接受ECCT治疗后，仅仅三个月的ECCT治疗就带来了显著的转变。2013年10月21日进行的随访CT扫描取得了令人鼓舞的结果：肺部未发现可检测的肿块，大部分肝脏肿块要么消失，要么大大缩小。尽管肝脏仍有一些结节，表明有死亡组织的沉淀，但其大小的减小表明取得了进展。Even in the latest ultrasound, the presence of nodules, albeit reduced in size, reinforced the suspicion of dead or stagnant masses in the liver. Despite these remnants, the patient's overall condition had notably improved in combating advanced lung cancer with liver metastasis.
即使在最新的超声检查中，结节的存在，虽然减小了，但仍加强了对肝脏中死亡或停滞肿块的怀疑。尽管存在这些残余物，但患者在对抗肺癌伴肝转移方面的整体状况明显有所改善。
Comments